MarketBeat
29 Oct 2026, 05:05 UTC · 1h ago
C.H. Robinson Worldwide Q3 Earnings Call Highlights
Impact · against what's priced in
CHRW provides a bullish update on margin expansion and revenue growth that the market has previously been skeptical of, though this is partially offset by rising SG&A and personnel costs. RXO remains a positive catalyst as a designated acquisition target.
- CHRW+0.40
Challenges what's priced in
- The price assumes
The full post-Montgomery operating margin expansion and cycle recovery
The market is not currently paying for a full margin recovery, but NAST and Global Forwarding margins (40.3% and 36.6%) have now exceeded mid-cycle targets, with NAST expanding over 1,500 bps since 2023.
What CHRW's price assumes · Sep 6
